Showing results (101-110 of 512) with videos related to

Sort By:
Pageof 52
Crohn'S & Colitis 360|July 16, 2026
Real-world outcomes of subcutaneous infliximab in a Middle Eastern inflammatory bowel disease cohort: a prospective study of switch and de novo treatment strategiesMaryam A Alahmad, Nadeen Mamon Omar, Mohammed Nabil Quraishi
Crohn'S & Colitis 360|June 29, 2026
The association between 6-thioguanine nucleotide levels, adalimumab exposure, immune response, and drug clearanceAndres Yarur, Jonathan C Lo, Bincy Abraham, et al.
Crohn'S & Colitis 360|June 30, 2026
Considerations in reviewing network meta-analyses of heterogeneous clinical trial designs: a methodological review in Crohn's disease and ulcerative colitisChristopher Ma, Eric B Collins, Si-Tien Wang, et al.
Crohn'S & Colitis 360|June 29, 2026
Stoma formation and associated risk factors in patients with Crohn's disease in an Austrian tertiary referral hospital: a retrospective explorative study of long-term follow-upChristian Primas, Stefan Riss, Jagoda Pokryszka, et al.
Crohn'S & Colitis 360|July 10, 2026
Agentic artificial intelligence in inflammatory bowel disease: toward autonomous and adaptive careAnimesh Acharjee, Daniela Santos
Crohn'S & Colitis 360|March 25, 2026
Pharmacokinetics and efficacy of subcutaneous infliximab 120 mg every 2 weeks: a post hoc comparison with intravenous dosing in a phase 1 study in patients with inflammatory bowel diseaseStefan Schreiber, Byong Duk Ye, Hyunseong Yu, et al.
Crohn'S & Colitis 360|March 27, 2026
Early proactive therapeutic drug monitoring with ustekinumab therapy in pediatric Crohn's disease: data from the prospective Canadian children IBD networkAmanda Ricciuto, Hayley E McKay, Jennifer C deBruyn, et al.
Crohn'S & Colitis 360|March 30, 2026
Child and parent perspectives in IBD management: a literature review and qualitative studyJennifer C deBruyn, Lara Hart, Gail MacKean, et al.
Crohn'S & Colitis 360|March 30, 2026
Impact of mirikizumab on patient-reported outcomes and quality of life in patients with Crohn's disease: results from the phase 2 SERENITY studyVipul Jairath, Theresa Hunter Gibble, Laurent Peyrin-Biroulet, et al.
Crohn'S & Colitis 360|August 12, 2026
Inflammatory burden index (CRP×NLR) is associated with moderate-to-severe endoscopic activity in hospitalized patients with ulcerative colitis: a single-center retrospective studyZihan Xu, Shiqing Yuan, Zhen Hu, et al.
Pageof 52